Midwest Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$231K Sell
3,303
-556
-14% -$40.6K 0.14% 94
2021
Q4
$300K Sell
3,859
-1,246
-24% -$110K 0.19% 83
2021
Q3
$487K Sell
5,105
-4,630
-48% -$489K 0.34% 79
2021
Q2
$1.21M Buy
9,735
+308
+3% +$36.8K 0.86% 52
2021
Q1
$1.24M Buy
9,427
+758
+9% +$104K 1.01% 44
2020
Q4
$1.15M Buy
+8,669
New +$1.05M 1.05% 41

Other funds holding EXAS

Midwest Wealth Management's EXAS Position: Q1 2022 in Review

Midwest Wealth Management reduced its Exact Sciences (EXAS) stake by 14% in Q1 2022, selling an estimated $40.6K and leaving 3,303 shares worth $231K. The position accounts for 0.14% of the portfolio, ranked #94.

Midwest Wealth Management first reported a position in EXAS in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.24M in Q1 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Midwest Wealth Management held 3,303 shares of Exact Sciences worth $231K as of Q1 2022.
  • Midwest Wealth Management sold 556 Exact Sciences shares in Q1 2022, an estimated $40.6K.
  • Exact Sciences made up 0.14% of Midwest Wealth Management's portfolio in Q1 2022, its #94 holding.
  • Midwest Wealth Management first reported a position in Exact Sciences in Q4 2020 and has held it in 6 quarters since.
  • Midwest Wealth Management's Exact Sciences position peaked at $1.24M in Q1 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Midwest Wealth Management's 13F filing for Q1 2022, filed 25 May 2022.